Clinical studies recruiting near Williamsville

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · RPCI Oncology, PC- Northtowns ( Site 0061) · Merck Sharp & Dohme LLC · NCT06136559 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Upstate Clinical Research Associates · Kallyope Inc. · NCT07674654 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · Upstate Clinical Research Associates, Merz Investigational S · Merz Therapeutics GmbH · NCT07018700 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0274 · Celgene · NCT05519085 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Phase 3 · Upstate Clinical Research Associates, Merz Investigational S · Merz Therapeutics GmbH · NCT07018713 A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' D
Phase 2 · Site Number - 1018 · Immunovant Sciences GmbH · NCT07018323 A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite
Phase N/A · University of Buffalo · Bayer · NCT07330258 Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Phase N/A · University at Buffalo · Boston Scientific Corporation · NCT02071134 The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
Phase 2 · SUNY Buffalo · University of Utah · NCT04372615 Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Phase 2 · Central Recruiting Site · Dogwood Therapeutics Inc. · NCT06848348 Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Phase 3 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT07398417 CEM-Plate and CEM-Cage First-In-Human Use Efficacy Study
NA · University at Buffalo Neurosurgery · ReVivo Medical, Corp. · NCT04883411 A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Phase 3 · Great Lakes Cancer Care ( Site 0047) · Merck Sharp & Dohme LLC · NCT06925737 A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
Phase 2 · Upstate Clinical Research Associates - Research Center · Ipsen · NCT06625060 Patient Retrospective Outcomes (PRO)
Phase N/A · Integrative Pain and Wellness Associates · Boston Scientific Corporation · NCT01550575 A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Upstate Clinical Research Associates · Kallyope Inc. · NCT07645924 A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insuli
Phase 3 · University at Buffalo · Novo Nordisk A/S · NCT07076199

Look up another city

Look up another condition